Evidence map›Paper›PMID 24615392›Full record

ArticleMolecular and cellular biochemistry2014

Identification of a new Mpl-interacting protein, Atp5d.

Hongyan Liu, Zhenhu Zhao, Yuxu Zhong, Yajun Shan, Xiaohong Sun, Bingzhi Mao, Yuwen Cong

Abstract read
PubMed Publisher
In one paragraph

Article in Molecular and cellular biochemistry, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.4field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 5 citations in OpenAlex.

  1. ATP5D Is a Potential Biomarker for Male Fertility.Oxidative medicine and cellular longevity · 2023
    Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Hongyan LiuBeijing Institute of Pharmacology and Toxicology, 27 Tai-Ping Road, Haidian District, Beijing, 100850, People's Republic of China, liuhyann@aliyun.com.
Zhenhu Zhao
Yuxu Zhong
Yajun Shan
Xiaohong Sun
Bingzhi Mao
Yuwen Cong
Beijing Haidian Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Thrombopoietin (TPO) can regulate hematopoiesis and megakaryopoiesis via activation of its receptor, c-Mpl, and multiple downstream signal transduction pathways. Using the cytoplasmic domain of Mpl as bait, we performed yeast two-hybrid screening, and found that the protein Atp5d might associate with Mpl. Atp5d is known as the δ subunit of mitochondrial ATP synthase, but little is known about the function of dissociative Atp5d. The interaction between Mpl and Atp5d was confirmed by the yeast two-hybrid system, mammalian two-hybrid assay, pull-down experiment, and co-immunoprecipitation study in vivo and in vitro. An additional immunofluorescence assay showed that the two proteins can colocalize along the plasma membrane in the cytoplasm. Using the yeast two-hybrid system, we tested a series of cytoplasmic truncated mutations for their ability to bind Atp5d and found an association between Atp5d and the Aa98-113 domain of Mpl. The dissociation of Atp5d from Mpl after TPO stimulation suggests that Atp5d may be a new component of TPO signaling.

Indexed as

AnimalsCell LineHumansIntracellular SpaceMiceMitochondrial Proton-Translocating ATPasesProtein BindingProtein Interaction Domains and MotifsProtein Interaction MapsProtein Structure, TertiaryProton-Translocating ATPasesReceptors, ThrombopoietinReproducibility of ResultsThrombopoietinTwo-Hybrid System TechniquesAtp5d protein, mouseMitochondrial Proton-Translocating ATPasesMpl protein, mouseProton-Translocating ATPasesReceptors, ThrombopoietinThrombopoietin

Identifiers

PMID24615392
OpenAlexW2003031394

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.